Stevens H, Eisenhardt SU, Shing KSCT, Nero TL, Morton CJ, Parker MW, Peter K, McFadyen JD. C-reactive protein, immunothrombosis and venous thromboembolism. Front Immunol. 2022;13:1002652. \[[PMC free article: PMC9513482](/pmc/articles/PMC9513482/)\] \[[PubMed: 36177015](https://pubmed.ncbi.nlm.nih.gov/36177015)\] 14. Zhang P, Mo D, Lin F, Dai H. Relationship between novel inflammatory markers derived from high-sensitivity C-reactive protein and heart failure: a cross-sectional study. BMC Cardiovasc Disord. 2025 Feb 18;25(1):111. \[[PMC free article: PMC11837360](/pmc/articles/PMC11837360/)\] \[[PubMed: 39966719](https://pubmed.ncbi.nlm.nih.gov/39966719)\] 15. Zhu M, Ma Z, Zhang X, Hang D, Yin R, Feng J, Xu L, Shen H. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis. BMC Med. 2022 Sep 19;20(1):301. \[[PMC free article: PMC9484145](/pmc/articles/PMC9484145/)\] \[[PubMed: 36117174](https://pubmed.ncbi.nlm.nih.gov/36117174)\] 16. Burger PM, Koudstaal S, Mosterd A, Fiolet ATL, Teraa M, van der Meer MG, Cramer MJ, Visseren FLJ, Ridker PM, Dorresteijn JAN., UCC-SMART study group. C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease. J Am Coll Cardiol. 2023 Aug 01;82(5):414-426. \[[PubMed: 37495278](https://pubmed.ncbi.nlm.nih.gov/37495278)\] 17. Luo YF, Cheng ZJ, Wang YF, Jiang XY, Lei SF, Deng FY, Ren WY, Wu LF. Unraveling the relationship between high-sensitivity C-reactive protein and frailty: evidence from longitudinal cohort study and genetic analysis. BMC Geriatr. 2024 Mar 04;24(1):222. \[[PMC free article: PMC10913347](/pmc/articles/PMC10913347/)\] \[[PubMed: 38439017](https://pubmed.ncbi.nlm.nih.gov/38439017)\] 18. Lee Y, McKechnie T, Doumouras AG, Handler C, Eskicioglu C, Gmora S, Anvari M, Hong D. Diagnostic Value of C-Reactive Protein Levels in Postoperative Infectious Complications After Bariatric Surgery: a Systematic Review and Meta-Analysis. Obes Surg. 2019 Jul;29(7):2022-2029. \[[PubMed: 30895509](https://pubmed.ncbi.nlm.nih.gov/30895509)\] 19. Johns I, Moschonas KE, Medina J, Ossei-Gerning N, Kassianos G, Halcox JP. Risk classification in primary prevention of CVD according to QRISK2 and JBS3 'heart age', and prevalence of elevated high-sensitivity C reactive protein in the UK cohort of the EURIKA study. Open Heart. 2018;5(2):e000849. \[[PMC free article: PMC6269641](/pmc/articles/PMC6269641/)\] \[[PubMed: 30564373](https://pubmed.ncbi.nlm.nih.gov/30564373)\] 20. Berman M, Ben-Ami R, Berliner S, Anouk M, Kaufman I, Broyde A, Borok S, Elkayam O. The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature. Life (Basel). 2021 Mar 20;11(3) \[[PMC free article: PMC8003879](/pmc/articles/PMC8003879/)\] \[[PubMed: 33804790](https://pubmed.ncbi.nlm.nih.gov/33804790)\] 21. Amezcua-Castillo E, González-Pacheco H, Sáenz-San Martín A, Méndez-Ocampo P, Gutierrez-Moctezuma I, Massó F, Sierra-Lara D, Springall R, Rodríguez E, Arias-Mendoza A, Amezcua-Guerra LM. C-Reactive Protein: The Quintessential Marker of Systemic Inflammation in Coronary Artery Disease-Advancing toward Precision Medicine. Biomedicines. 2023 Sep 02;11(9) \[[PMC free article: PMC10525787](/pmc/articles/PMC10525787/)\] \[[PubMed: 37760885](https://pubmed.ncbi.nlm.nih.gov/37760885)\] 22. Guo L, Huang Y, He J,